Altered Sensitivity of Aspirin-Acetylated Prostaglandin G/H Synthase-2 to Inhibition by Nonsteroidal Anti-Inflammatory Drugs
- 1 January 1997
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 51 (1) , 52-60
- https://doi.org/10.1124/mol.51.1.52
Abstract
Aspirin (ASA) acetylates Ser516 of prostaglandin G/H synthase-2 (PGHS-2) resulting in a modified enzyme that converts arachidonic acid to 15(R)-hydroxy-eicosatetraenoic acid [15(R)-HETE]. ASA has pharmacological benefits that may not all be limited to inhibition of prostaglandin synthesis, and this study was initiated to further investigate the properties of ASA-acetylated PGHS-2 and of the mutation of Ser516 to methionine, which mimics ASA acetylation. Both the S516M mutant and ASA-acetylated form of PGHS-2 (ASA-PGHS-2) synthesize 15(R)-HETE and have apparent Km values for arachidonic acid within 10-fold of the apparentKm value for untreated PGHS-2. The time courses of turnover-dependent inactivation were similar for reactions catalyzed by PGHS-2 and ASA-PGHS-2, whereas the PGHS-2(S516M) showed a decrease in both the initial rate of 15-HETE production and rate of enzyme inactivation. The production of 15-HETE by modified PGHS-2 was sensitive to inhibition by most nonsteroidal anti-inflammatory drugs (NSAIDs), including selective PGHS-2 inhibitors. As observed for the cyclooxygenase activity of PGHS-2, the inhibition of 15-HETE production by indomethacin was time-dependent for both ASA-PGHS-2 and PGHS-2(S516M). However, two potent, structurally related NSAIDs, diclofenac and meclofenamic acid, do not inhibit either ASA-PGHS-2 or the PGHS-2(S516M) mutant. These results demonstrate that the sensitivity to inhibition by NSAIDs of the 15-HETE production by ASA-treated PGHS-2 is different than that of prostaglandin production by PGHS-2 and that Ser516 plays an important role in the interaction with fenamate inhibitors. The results also indicate that the conversion of arachidonic acid to 15-HETE by ASA-PGHS-2 is an efficient process providing a unique mechanism among NSAIDs that will not lead to arachidonic acid accumulation or shunting to other biosynthetic pathways.Keywords
This publication has 39 references indexed in Scilit:
- NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesionsPublished by Elsevier ,2002
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Arginine 120 of Prostaglandin G/H Synthase-1 Is Required for the Inhibition by Nonsteroidal Anti-inflammatory Drugs Containing a Carboxylic Acid MoietyJournal of Biological Chemistry, 1995
- Comparison of recombinant cyclooxygenase‐2 to native isoforms: aspirin labeling of the active siteFEBS Letters, 1995
- The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthaseNature Structural & Molecular Biology, 1995
- Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus systemBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesisFEBS Letters, 1994
- The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1Nature, 1994
- Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized TrialJNCI Journal of the National Cancer Institute, 1993
- Prostaglandin endoperoxide synthase: structure and catalysisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991